9Bio uses experimental measurements of engineered antibodies to inform its AI-driven optimization program. Its traditional binding systems required specialist equipment and trained operators, adding time and cost to the work.
Through VICA™, Pavonis provided binding validation, pH testing and kinetics. The studies delivered the analysis 9Bio needed at lower cost and with more flexibility, reducing the equipment and training barriers to experimental testing. With those barriers reduced, the work helped accelerate 9Bio’s discovery program.